Search research articles
Contact Us
Filters
Showing results (51-60 of 68) with videos related to
Page
of 7
Sort By:
Pathology
|
October 7, 2023
Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancer
Shona Hendry, Louis Mamotte, Nima Mesbah Ardakani, et al.
Asia-Pacific Journal of Clinical Oncology
|
May 10, 2014
KRAS mutation testing of metastatic colorectal cancer in Australia: where are we at?
Rodney J Scott, Stephen B Fox, Jayesh Desai, et al.
The Journal of Molecular Diagnostics : JMD
|
January 7, 2018
Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues: A Comparison with Sanger Sequencing and Pyrosequencing
Ashleigh C McEvoy, Benjamin A Wood, Nima M Ardakani, et al.
Cancer Reports (Hoboken, N.J.)
|
September 2, 2025
Routine Tumor Testing for Homologous Recombination Deficiency in Patients With High Grade Epithelial Ovarian Cancer at a Statewide Gynecological Cancer Service in Western Australia: An Observational Study
Kaamini Planisamy, Elena Ctori, Benhur Amanuel, et al.
Oncotarget
|
November 8, 2017
Sensitive droplet digital PCR method for detection of <i>TERT</i> promoter mutations in cell free DNA from patients with metastatic melanoma
Ashleigh C McEvoy, Leslie Calapre, Michelle R Pereira, et al.
Histopathology
|
April 8, 2015
Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing
Christina Selinger, Wendy Cooper, Trina Lum, et al.
Scientific Reports
|
April 16, 2013
A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma
Anna Richter, Fabienne Grieu, Amerigo Carrello, et al.
Oncotarget
|
February 23, 2018
Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples
Ross A Soo, Joey Sze Yun Lim, Bernadette Reyna Asuncion, et al.
Molecular Oncology
|
October 13, 2018
Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma
Leslie Calapre, Tindaro Giardina, Cleo Robinson, et al.
International Journal of Cancer
|
January 30, 2014
Population-based screening for Lynch syndrome in Western Australia
Lyn Schofield, Fabienne Grieu, Benhur Amanuel, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 68) with videos related to
Sort By:
Page
of 7
Pathology
|
October 7, 2023
Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancer
Shona Hendry, Louis Mamotte, Nima Mesbah Ardakani, et al.
Asia-Pacific Journal of Clinical Oncology
|
May 10, 2014
KRAS mutation testing of metastatic colorectal cancer in Australia: where are we at?
Rodney J Scott, Stephen B Fox, Jayesh Desai, et al.
The Journal of Molecular Diagnostics : JMD
|
January 7, 2018
Droplet Digital PCR for Mutation Detection in Formalin-Fixed, Paraffin-Embedded Melanoma Tissues: A Comparison with Sanger Sequencing and Pyrosequencing
Ashleigh C McEvoy, Benjamin A Wood, Nima M Ardakani, et al.
Cancer Reports (Hoboken, N.J.)
|
September 2, 2025
Routine Tumor Testing for Homologous Recombination Deficiency in Patients With High Grade Epithelial Ovarian Cancer at a Statewide Gynecological Cancer Service in Western Australia: An Observational Study
Kaamini Planisamy, Elena Ctori, Benhur Amanuel, et al.
Oncotarget
|
November 8, 2017
Sensitive droplet digital PCR method for detection of <i>TERT</i> promoter mutations in cell free DNA from patients with metastatic melanoma
Ashleigh C McEvoy, Leslie Calapre, Michelle R Pereira, et al.
Histopathology
|
April 8, 2015
Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing
Christina Selinger, Wendy Cooper, Trina Lum, et al.
Scientific Reports
|
April 16, 2013
A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma
Anna Richter, Fabienne Grieu, Amerigo Carrello, et al.
Oncotarget
|
February 23, 2018
Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples
Ross A Soo, Joey Sze Yun Lim, Bernadette Reyna Asuncion, et al.
Molecular Oncology
|
October 13, 2018
Locus-specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma
Leslie Calapre, Tindaro Giardina, Cleo Robinson, et al.
International Journal of Cancer
|
January 30, 2014
Population-based screening for Lynch syndrome in Western Australia
Lyn Schofield, Fabienne Grieu, Benhur Amanuel, et al.
Page
of 7